Publication: Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis
| dc.contributor.author | Rodniem, Siripa | |
| dc.contributor.author | Tiyao, Vilailak | |
| dc.contributor.author | Nilbu nga, Cheng | |
| dc.contributor.author | Poonkhum, Raksawan | |
| dc.contributor.author | Pongmayteegul, Sirinun | |
| dc.contributor.author | Pradidarcheep, Wisuit | |
| dc.date.accessioned | 2022-06-17T09:43:35Z | |
| dc.date.available | 2022-06-17T09:43:35Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Liver fibrosis is an excessive accumulation of scar tissue resulting from inflammation and cell death. Thioacetamide (TAA) is a well-known hepatotoxin that induces liver fibrosis. A marker of injured hepatocytes is transforming growth factor-beta 1 (TGF-β1), while alpha-smooth muscle actin (α-SMA) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are markers of activated hepatic stellate cells. Alpha-mangostin, a major xanthone derivative from the mangosteen pericarp, has been shown to have anti-oxidant and anti-inflammatory activities. The objective of this study was to determine whether alpha-mangostin has a protective effect on TAA-induced liver fibrosis in rats. The rats were treated by intraperitoneal injection of compounds for eight weeks. For the control group a mixture of dimethyl sulfoxide and phosphate buffered saline was administered. Two hundred mg/kg BW of TAA was administered three times weekly. Alpha-mangostin was administered at 5 mg/kg BW and silymarin at 100 mg/kg BW, both twice weekly. TAA induced histologically recognizable liver damage and fibrosis, as anticipated. Furthermore, it increased immunohistochemically detectable TGF-β1, α-SMA, and TIMP-1. Coadministration of alpha-mangostin or silymarin with TAA prevented or ameliorated the effects of TAA administration alone. The anti-fibrotic effect of alphamangostin was stronger than that of silymarin. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 12 | es |
| dc.identifier.citation | Histology and Histopathology, Vol.34, nº4, (2019) | |
| dc.identifier.doi | DOI: 10.14670/HH-18-052 | |
| dc.identifier.issn | 1699-5848 | |
| dc.identifier.issn | 0213-3911 | |
| dc.identifier.uri | http://hdl.handle.net/10201/121465 | |
| dc.language | eng | es |
| dc.publisher | Universidad de Murcia. Departamento de Biología Celular e Histología | es |
| dc.relation | Sin financiación externa a la Universidad | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Liver fibrosis | es |
| dc.subject | Thioacetamide | es |
| dc.subject | Alphamangostin | es |
| dc.subject | Herb | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología | es |
| dc.title | Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/